FR2377201A1 - Composition pharmaceutique a activite anti-inflammatoire et vasculotrope - Google Patents

Composition pharmaceutique a activite anti-inflammatoire et vasculotrope

Info

Publication number
FR2377201A1
FR2377201A1 FR7701290A FR7701290A FR2377201A1 FR 2377201 A1 FR2377201 A1 FR 2377201A1 FR 7701290 A FR7701290 A FR 7701290A FR 7701290 A FR7701290 A FR 7701290A FR 2377201 A1 FR2377201 A1 FR 2377201A1
Authority
FR
France
Prior art keywords
vitamin
esp
pref
vasculotropic
compsns
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7701290A
Other languages
English (en)
Other versions
FR2377201B1 (fr
Inventor
Hubert Serre
Jean Rey
Jean-Pierre Tarayre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre SA
Original Assignee
Pierre Fabre SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre SA filed Critical Pierre Fabre SA
Priority to FR7701290A priority Critical patent/FR2377201A1/fr
Publication of FR2377201A1 publication Critical patent/FR2377201A1/fr
Application granted granted Critical
Publication of FR2377201B1 publication Critical patent/FR2377201B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne une composition pharmaceutique à activité anti-inflammatoire et vasculotrope. La composition selon l'invention se caractérise par le fait qu'elle comprend, à titre de principes actifs, un complexe enzymatique protéolytique à propriétés vasculotropes incorporant un extrait de Ruscus Aculeatus L et au moins un facteur vitaminique P. Application, notamment pour le traitement de troubles fonctionnels liés à l'insuffisance veineuse et à la fragilité capillaire losqu'il y a participation inflammatoire.
FR7701290A 1977-01-18 1977-01-18 Composition pharmaceutique a activite anti-inflammatoire et vasculotrope Granted FR2377201A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7701290A FR2377201A1 (fr) 1977-01-18 1977-01-18 Composition pharmaceutique a activite anti-inflammatoire et vasculotrope

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7701290A FR2377201A1 (fr) 1977-01-18 1977-01-18 Composition pharmaceutique a activite anti-inflammatoire et vasculotrope

Publications (2)

Publication Number Publication Date
FR2377201A1 true FR2377201A1 (fr) 1978-08-11
FR2377201B1 FR2377201B1 (fr) 1979-04-20

Family

ID=9185607

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7701290A Granted FR2377201A1 (fr) 1977-01-18 1977-01-18 Composition pharmaceutique a activite anti-inflammatoire et vasculotrope

Country Status (1)

Country Link
FR (1) FR2377201A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2556969A1 (fr) * 1983-12-27 1985-06-28 Oreal Composition cosmetique ou pharmaceutique a base d'extraits vegetaux ayant une action sur la fragilite capillaire
EP2060183A3 (fr) * 1996-10-16 2009-06-03 Napo Pharmaceuticals, Inc. Formulations enterales des compositions polymeres pro-anthocyanidiques à propriétés anti-diarrheiques
FR3032620A1 (fr) * 2015-02-18 2016-08-19 Pf Medicament Utilisation d'un extrait de ruscus dans le traitement de l'insuffisance veineuse chez des patients dont les veines pathologiques presentent une reponse fonctionnelle vasodilatatrice a l'acetylcholine alteree
CN107913401A (zh) * 2016-10-08 2018-04-17 江阴市本特塞缪森生命科学研究院有限公司 胰蛋白酶产品及治疗妇科炎症的应用

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2556969A1 (fr) * 1983-12-27 1985-06-28 Oreal Composition cosmetique ou pharmaceutique a base d'extraits vegetaux ayant une action sur la fragilite capillaire
EP0147331A2 (fr) * 1983-12-27 1985-07-03 L'oreal Composition cosmétique ou pharmaceutique à base d'extraits végétaux ayant une action sur la fragilité capillaire
EP0147331A3 (en) * 1983-12-27 1985-07-31 L'oreal Cosmetic or pharmaceutical composition on the basis of plant extracts having an effect on the capillary fragility
US4942033A (en) * 1983-12-27 1990-07-17 L'oreal Vegetable extract-based cosmetic or pharmaceutical composition which acts on capillary brittleness
EP2060183A3 (fr) * 1996-10-16 2009-06-03 Napo Pharmaceuticals, Inc. Formulations enterales des compositions polymeres pro-anthocyanidiques à propriétés anti-diarrheiques
EP2255661A3 (fr) * 1996-10-16 2010-12-22 Napo Pharmaceuticals, Inc. Formulations enterales des compositions polymeres pro-anthocyanidiques à propriétés anti-diarrheiques
US8574634B2 (en) 1996-10-16 2013-11-05 Napo Pharmaceutcials, Inc. Compositions and methods of treatment with proanthocyanidin polymer antidiarrheal compositions
FR3032620A1 (fr) * 2015-02-18 2016-08-19 Pf Medicament Utilisation d'un extrait de ruscus dans le traitement de l'insuffisance veineuse chez des patients dont les veines pathologiques presentent une reponse fonctionnelle vasodilatatrice a l'acetylcholine alteree
WO2016131897A1 (fr) * 2015-02-18 2016-08-25 Pierre Fabre Medicament Utilisation d'un extrait de ruscus dans le traitement de l'insuffisance veineuse chez des patients dont les veines pathologiques presentent une reponse fonctionnelle vasodilatatrice a l'acetylcholine alteree
CN107913401A (zh) * 2016-10-08 2018-04-17 江阴市本特塞缪森生命科学研究院有限公司 胰蛋白酶产品及治疗妇科炎症的应用

Also Published As

Publication number Publication date
FR2377201B1 (fr) 1979-04-20

Similar Documents

Publication Publication Date Title
ZA874635B (en) Novel anti-inflammatory agents,pharmaceutical compositions and methods for reducing inflammation
EP0062000A3 (en) Use of 4-aminosalicylic acid as an anti-inflammatory agent
EP0402950A3 (fr) Traitement de troubles postménopausiques
EP0136011A3 (fr) Méthode de traitement hormonal de troubles de la périménopause, ménopause et postménopause et emballage à préparations multiples dans ce but
HUP0000558A3 (en) Use of active d vitamin analogues for producing pharmaceutical composition for the treatment of prostatic diseases
CA2289717A1 (fr) Nouveau traitement de la constipation
IE790756L (en) Cerebral therapeutic agent
NO175042C (fr)
SG54210A1 (en) Oral composition for the treatment of bowel inflammatory bowel diseases
ES8403024A1 (es) Un procedimiento para la fabricacion de un preparado farmaceutico para uso externo, a base de un compuesto no esteroi- dico.
ITRM920270A0 (it) Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale.
MY108146A (en) Medicaments for treating inflammatory conditions or for analgesia
DE2963572D1 (en) Mercapto-imidazole derivatives, their preparation, mercapto-imidazole derivatives for the treatment of inflammatory diseases and their pharmaceutical compositions
AU2690684A (en) Methods and pharmaceutical compositions for the treatment of hyperplastic diseases of the skin
NO158417C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive urinstoffer og tiourinstoffer.
AR009113A1 (es) UN PRODUCTO ANTICONCEPTIVO PARA DETENER LA OVULACIoN EN MUJERES DURANTE SU PERIODO DE ACTIVIDAD OVÁRICA
JPS5218813A (en) Plasters for the relief of cutaneous diseases
FR2377201A1 (fr) Composition pharmaceutique a activite anti-inflammatoire et vasculotrope
DE3479728D1 (en) Derivatives of thiophenesulfonamide, their preparation and pharmaceutical composition for the topical treatment of elevated intraocular pressure
IE831863L (en) Fatty acid compositions.
EP0161816A3 (fr) Urogastrone
EP0256805A3 (fr) Compositions pharmaceutiques pour le traitement de maladies des systèmes vasculaires occlus
ES8706027A1 (es) Procedimiento de obtencion de una composicion para el tratamiento de vitiligo
ES8307230A1 (es) "un procedimiento para la preparacion de oxaprocin calcico".
IT1150752B (it) Dispositivo sanitario per una crio-farmaco terapia topica sintomatica di malattie benigne ano-rettali, in particolari di emorroidi

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse